TY  - RPRT
TI  - Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab
AU  - Routh, E. D.
AU  - Woodcock, M. G.
AU  - Serody, J. S.
AU  - Vincent, B. G.
PY  - 2022
DO  - 10.1101/2022.08.19.504403
UR  - https://www.biorxiv.org/content/10.1101/2022.08.19.504403v1
ID  - 10.1101/2022.08.19.504403
ER  -